Team:Freiburg/Results

From 2014.igem.org

(Difference between revisions)
Line 4: Line 4:
<style>
<style>
.header-right {
.header-right {
-
   background: -moz-linear-gradient(0deg, #181617 0%, #181617 10%, rgba(24, 22, 23, 0) 30%), url(https://static.igem.org/mediawiki/2014/4/41/Freiburg2014-09-11_NIH3T3_EGFP_80%25_header_Thumbnail.jpg);
+
   background: -moz-linear-gradient(0deg, #181617 0%, #181617 10%, rgba(24, 22, 23, 0) 30%), url(https://static.igem.org/mediawiki/2014/0/0f/Freiburg2014-09-24_NIH3t3_transduced_with_MuLV_EGFP_header_Thumbnail.jpg);
-
   background: -webkit-linear-gradient(0deg, #181617 0%, #181617 10%, rgba(24, 22, 23, 0) 30%), url(https://static.igem.org/mediawiki/2014/4/41/Freiburg2014-09-11_NIH3T3_EGFP_80%25_header_Thumbnail.jpg);
+
   background: -webkit-linear-gradient(0deg, #181617 0%, #181617 10%, rgba(24, 22, 23, 0) 30%), url(https://static.igem.org/mediawiki/2014/0/0f/Freiburg2014-09-24_NIH3t3_transduced_with_MuLV_EGFP_header_Thumbnail.jpg);
-
   background: linear-gradient(90deg, #181617 0%, #181617 10%, rgba(24, 22, 23, 0) 30%), url(https://static.igem.org/mediawiki/2014/4/41/Freiburg2014-09-11_NIH3T3_EGFP_80%25_header_Thumbnail.jpg);
+
   background: linear-gradient(90deg, #181617 0%, #181617 10%, rgba(24, 22, 23, 0) 30%), url(https://static.igem.org/mediawiki/2014/0/0f/Freiburg2014-09-24_NIH3t3_transduced_with_MuLV_EGFP_header_Thumbnail.jpg);
   background-size: 100% auto, 100% auto;
   background-size: 100% auto, 100% auto;
   background-position: center center, center center;
   background-position: center center, center center;

Revision as of 15:40, 16 October 2014

The AcCELLerator

Summary



We, the iGEM Team Freiburg 2014, have the goal to combine the capability of viral vectors for stable gene transfer with the spatio-temporal resolution of optogenetics for gene delivery into mammalian cells. We utilized the Murine Leukemia Virus (MuLV) that specifically uses the murine mCAT-1 receptor to infect target cells. By using a blue light inducible expression system, we brought the receptor to the plasma membrane of illuminated cells to enable targeted gene delivery by the virus.

Our project was quite a large success! We:

  • produced MuLV viruses containing different reporter proteins,
  • optimized MuLV production and transduction protocols to reach close to 100% efficiency,
  • created stable mammalian cell lines using the MuLV virus,
  • generated patterns of reporter proteins in cell cultures by light exposure,
  • demonstrated that the virus exclusively infects cells expressing the mCAT-1 receptor,
  • infected cells with the MuLV virus that expressed the mCAT-1 receptor after light induction.

We provide the virus as a tool for the generation of stable mammalian cell lines under biosafety level 1 regulations. Our viral vector, which we propose as a new iGEM RFC, enables the user to introduce any gene of interest stably into mammalian cell lines. Therefore we provide for the iGEM community a fast, easy to handle and safe way of generating stable cell lines.

During the course of iGEM, we learned many new techniques:

  • mammalian cell culture,
  • fluorescence activated cell sorting,
  • virus production under biosafety level 1 and biosafety level 2 conditions,
  • many different cloning techniques,
  • widefield and confocal microscopy,
  • creating a website,

and, last but not least, we had a lot of fun and learned how to work together as a team!